In Vitro Development of Resistance to Six and Four Fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, Respectively

ABSTRACT Selection of resistant mutants in sequential subcultures with increasing concentrations of six and four different fluoroquinolones was studied for one reference strain each of Mycoplasma pneumoniae and Mycoplasma hominis, respectively. All fluoroquinolones tested selected for resistance, with alterations affecting the quinolone resistance-determining regions of the four target topoisomerase genes.

[1]  A. Nangia,et al.  Correction , 2004, Journal of Clinical Pathology.

[2]  S. Pereyre,et al.  In Vitro Selection and Characterization of Resistance to Macrolides and Related Antibiotics in Mycoplasma pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.

[3]  S. Pereyre,et al.  DNA Gyrase and Topoisomerase IV Mutations in Clinical Isolates of Ureaplasma spp. and Mycoplasma hominis Resistant to Fluoroquinolones , 2003, Antimicrobial Agents and Chemotherapy.

[4]  F. Tenover,et al.  DNA Gyrase and Topoisomerase IV Mutations Associated with Fluoroquinolone Resistance in Proteus mirabilis , 2002, Antimicrobial Agents and Chemotherapy.

[5]  A. Charron,et al.  Evidence of Active Efflux in Resistance to Ciprofloxacin and to Ethidium Bromide by Mycoplasma hominis , 2002, Antimicrobial Agents and Chemotherapy.

[6]  T. Deguchi,et al.  Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment. , 2001, The Journal of antimicrobial chemotherapy.

[7]  M. Jacobs,et al.  Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae. , 2001, The Journal of antimicrobial chemotherapy.

[8]  W. M. Huang,et al.  Sparfloxacin Selects Gyrase Mutations in First-Step Mycoplasma hominis Mutants, whereas Ofloxacin Selects Topoisonmerase IV Mutations , 1999, Antimicrobial Agents and Chemotherapy.

[9]  T. Schaeverbeke,et al.  Mutations in the gyrA, parC, and parE Genes Associated with Fluoroquinolone Resistance in Clinical Isolates of Mycoplasma hominis , 1999, Antimicrobial Agents and Chemotherapy.

[10]  J. Bové,et al.  Alterations in Topoisomerase IV and DNA Gyrase in Quinolone-Resistant Mutants of Mycoplasma hominis Obtained In Vitro , 1998, Antimicrobial Agents and Chemotherapy.

[11]  H. Hilbert,et al.  Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. , 1996, Nucleic acids research.

[12]  P. Heisig,et al.  Mechanisms of quinolone resistance , 2005, Infection.